Send2Press › Wire › Kalyagen News Room and Media Kit

Kalyagen Newsroom - Profile and News Archive

Kalyagen™ was founded by Christian Drapeau, author of the bestseller Cracking the Stem Cell Code. Kalyagen is a leader in the research and development of natural products aimed at supporting stem cell function of the body. Stem cells constitute the natural repair system of the body, and stem cell enhancers have been documented to strongly contribute to improving health and quality of life.

STEMREGEN® is the first stem cell enhancer product developed by Kalyagen™. STEMREGEN is a unique blend of proprietary plant-based extracts documented to support Endogenous Stem Cell Mobilization and provide other health benefits.

Media Contact:
Biomics, LLC (dba Kalyagen™)
Herbert Dogan
Chief Marketing Officer
(310-433-8072)
hgd@kalyagen.com

Engage with Kalyagen

Learn more online at: https://www.kalyagen.com/

Follow:  Twitter  |  Facebook  |  Instagram  |  YouTube

RSS News Feed for Kalyagen

Press Releases from Kalyagen :

Kalyagen Announces Release of Free eBook on How to Optimize Health Using Stem Cells

KALYAGEN

AUSTIN, Texas, July 14, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen® has announced the release and availability of a free eBook, “The Stemregen Effect – Tapping into the Power of Your Own Stem Cells,” which provides an overview of how stem cells are the body’s repair system and how STEMREGEN®, a natural stem cell enhancer, has been documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

Kalyagen and Uniwell Announce Partnership to Manufacture Proprietary and Third-Party Skin Care Products

Skin care production line at Uniwell

AUSTIN and FORT WORTH, Texas, June 15, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen® and Uniwell Laboratories announced today that they have entered into a joint venture to produce the unique, patent-pending Juviqa Stem Cell Beauty System and expand Uniwell’s manufacturing capabilities to include cosmetics.

Kalyagen and Intelicure Announce Partnership to Distribute STEMREGEN in Canada

KALYAGEN

AUSTIN, Texas and VANCOUVER, B.C., June 4, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen® and Intelicure Health Inc. announced today that they have entered into an agreement to promote and distribute throughout Canada STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

Kalyagen Announces Next ‘The Stemregen Effect’ Commercial Featuring Chris Spencer to be Filmed in Belize

KALYAGEN

AUSTIN, Texas, May 13, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen™ is pleased to announce that the next part of “The Stemregen Effect” digital media campaign will be filmed in Belize and feature actor, comedian, writer and producer Chris Spencer to promote STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

Kalyagen Announces Release of ‘The Stemregen Effect’ Commercial with Three Former UCLA Players to Coincide with the Bruins Advancing to the Final Four

Kalyagen Announces Release of ‘The Stemregen Effect’ Commercial

AUSTIN, Texas, April 3, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen™ is pleased to announce the release of its “The Stemregen Effect” social media ad featuring former UCLA Bruins and NBA players Niguel Miguel, Marques Johnson and Mitchell Butler to promote STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

Kalyagen Announces Launch of ‘Stem the Tide of Time’ Campaign Featuring NBA Hall of Fame Finalist Marques Johnson

KALYAGEN

AUSTIN, Texas, Feb. 8, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen is pleased to announce the launch of its “Stem the Tide of Time” social media campaign featuring former UCLA Bruin and Milwaukee Buck All-Star Marques Johnson to promote STEMREGEN;, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM). (VIDEO)

Kalyagen™ Announces Launch of Clinical Trial to Evaluate STEMREGEN® and Stem Cells for Advanced Heart Failure Patients

KALYAGEN

AUSTIN, Texas, Feb. 5, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the “Spanish Society of Regenerative Medicine and Cell Therapy”), is pleased to announce the launch of a multicenter clinical trial, “The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure,” to evaluate the use of stem cell therapies in patients suffering from heart failure.